Lifesciences Technologies
The Development of Enabling Technologies for Proteomic and Genomics Research - Beta Testing
The rapid escalation of activity in genomics research has been sparked by the introduction of advanced technology such as automated DNA sequencers. The emerging focus of 21st-century biology is shifting to the large-scale analysis of entire cellular proteomes. Technologies that enable researchers to do more, faster, must be developed that provide the depth of information demanded by such studies. Through the Enabling Technologies (ET) Project, research groups from MDS Sciex, Advanced Integrated MicroSystems (AIMS) and five Canadian universities are creating innovative tools that extend the bioanalytical capabilities of scientists in the fields of genomics and proteomics. MDS Sciex, a world-leading manufacturer of mass spectrometry products, acts as the lead research organization for the ET Project.
Read more
